SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

145.06

461847.99

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.83

Back

Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter

Jul 31,2026

Net profit of Sun Pharmaceutical Industries rose 27.04% to Rs 2894.79 crore in the quarter ended June 2026 as against Rs 2278.63 crore during the previous quarter ended June 2025. Sales rose 10.14% to Rs 15183.55 crore in the quarter ended June 2026 as against Rs 13786.07 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	15183.55	13786.07	10
OPM %	29.10	31.20	-
PBDT	5041.62	4691.32	7
PBT	4302.90	3990.77	8
NP	2894.79	2278.63	27

78,009.25 -70.71 ( -0.09%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)